We recently published a list of the 20 Best Dividend Growth Stocks with High Yields. In this article, we are going to take a ...

Merck (MRK) stock gains as its bestselling drug, Keytruda, as part of a combination regimen, succeeds in a Phase 3 trial for ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck is facing an awkward encore as one of the worst-performing blue chip stocks in 2025, sliding 23.3% year-to-date.

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other worst blue chip stocks to buy.

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q1 2025 Earnings Call Transcript May 9, 2025 Rapid Micro Biosystems, Inc. beats ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

Merck is shelling out $895 million to beef up its De Soto, Kansas facility, giving its Animal Health division a mighty boost. This project aims to generate 2,500 construction jobs and launch ...